Impact of Hormone Replacement Therapy on Breast Cancer Risk Following Oophorectomy in Women with BRCA Pathogenic Variants
Overview
This study investigates the association between hormone replacement therapy (HRT) and breast cancer risk in women with BRCA1 or BRCA2 pathogenic variants following risk-reducing bilateral oophorectomy (RRBO). Findings suggest that estrogen-only HRT does not increase breast cancer risk, while progestin-containing regimens may be associated with higher risk.
Background
Women with BRCA1 and BRCA2 pathogenic variants face significantly elevated risks for breast and ovarian cancers. Risk-reducing bilateral salpingo-oophorectomy is recommended to mitigate ovarian cancer risk, but it leads to early menopause, prompting consideration of hormone replacement therapy. The lack of international guidelines on HRT use in this population complicates clinical decision-making.
Data Highlights
No numerical data provided in the source material.
Key Findings
Estrogen-only HRT after RRBO was not associated with increased breast cancer risk in women with BRCA1 PV.
Progestin-containing HRT regimens were linked to a higher risk of breast cancer.
In a cohort of 872 women with BRCA1 PV, estrogen-only therapy showed a reduced breast cancer risk (HR, 0.78).
Combined estrogen-progestin regimens were associated with an elevated breast cancer risk (HR, 1.28).
Further studies are needed to clarify the relationship between HRT formulations and breast cancer risk in women with BRCA PVs.
Clinical Implications
Clinicians should consider the type of hormone replacement therapy prescribed to women with BRCA pathogenic variants after oophorectomy, as estrogen-only therapy may be safer than combined regimens. Individualized counseling is essential to balance the benefits of HRT against potential breast cancer risks.
Conclusion
The findings underscore the need for careful evaluation of hormone replacement therapy options in women with BRCA pathogenic variants post-oophorectomy, highlighting the importance of personalized treatment strategies.
